Dow Up 1.32% Nasdaq Up 1.60%

Endocyte, Inc. (ECYT)

-NasdaqGS
5.61 0.02(0.36%) Oct 23, 4:00PM EDT
Prev Close:5.63
Open:5.68
Bid:5.14 x 300
Ask:6.82 x 200
1y Target Est:13.11
Beta:0.97
Next Earnings Date: 5-Nov-14ECYT Earnings announcement
Day's Range:5.57 - 5.77
52wk Range:5.31 - 33.70
Volume:577,468
Avg Vol (3m):1,422,530
Market Cap:233.10M
P/E (ttm):16.12
EPS (ttm):0.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ECYT

Comparison

Symbol% ChgMkt Cap
ECYTDown 0.36%233.10M
NKTR1.69B
RHHBY249.03B
SNSS86.43M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Sep-14) :-0.21
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback